Although previous studies have suggested that the leukemic fusion protein AML1-ETO blocks differentiation by dysregulating RUNX1 target genes, recent data actually suggest a positive role for RUNX1 in leukemia (Goyama et al., 2013). The gene discussed is RUNX1T1; the disease is leukemia.